PPLFF yields 5.11% · JNJ yields 2.14%● Live data
📍 PPLFF pulled ahead of the other in Year 1
Combined, PPLFF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of PPLFF + JNJ for your $10,000?
PT Perusahaan Perkebunan London Sumatra Indonesia Tbk, together with its subsidiaries, engages in the plantation business in Indonesia. The company operates through Oil Palm Products, Rubber, Seeds, and Other Product segments. It offers crude palm oil, rubber, cocoa, tea, and oil palm seeds. The company also develops plantations on behalf of local smallholders. As of December 31, 2021, it had a total planted area of 114,111 hectares comprising 93,853 hectares of palm oil; 16,228 hectares of rubber; and 4,030 hectares of cocoa, tea, and other crops in North Sumatra, South Sumatra, East Kalimantan, North Sulawesi, South Sulawesi, and Java. The company is also involved in the research, processing, trading, marketing, industrial, and agency/representative activities; and invests in agricultural technology and cultivation, as well as agriculture, forestry, and fishery businesses. It exports its products. The company was founded in 1906 and is headquartered in Jakarta Selatan, Indonesia. PT Perusahaan Perkebunan London Sumatra Indonesia Tbk is a subsidiary of PT Salim Ivomas Pratama Tbk.
Full PPLFF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.